Stratifying Patients with Haematuria into High or Low Risk Groups for Bladder Cancer: a Novel Clinical Scoring System |
Tan, Guan Hee
(Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia)
Shah, Shamsul Azhar (Department of Community Health, Universiti Kebangsaan Malaysia) Ann, Ho Sue (Department of Surgery, Universiti Kebangsaan Malaysia) Hemdan, Siti Nurhafizah (Department of Surgery, Universiti Kebangsaan Malaysia) Shen, Lim Chun (Department of Surgery, Universiti Kebangsaan Malaysia) Abdul Galib, Nurudin Al-Fahmi (Department of Surgery, Universiti Kebangsaan Malaysia) Singam, Praveen (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia) Kong, Ho Chee Christopher (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia) Hong, Goh Eng (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia) Bahadzor, Badrulhisham (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia) Zainuddin, Zulkifli Md (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia) |
1 | Messing E (2007). Markers of detection. Urol Oncol, 25, 344-7. DOI ScienceOn |
2 | Messing EM, Young TB, Hunt VB, et al (1987). The signiWcance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol, 137, 919-22. DOI |
3 | Alishahi S, Byrne D, Goodman CM, et al (2002). Haematuria investigation based on a standard protocol: emphasis on the diagnosis of urological malignancy. J R Coll Surg Edinb, 47, 422-7. |
4 | Buntinx F, Wauters H (1997). The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta- analysis. Fam Pract, 14, 63-8. DOI ScienceOn |
5 | Summerton N, Mann S, Rigby AS, et al (2002). Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. Br J Gen Pract, 52, 284-9. |
6 | Wallace DMA, Bryan RT, Dunn JA, et al (2002). Delay and survival in bladder cancer. BJU Int, 89, 868-78. DOI ScienceOn |
7 | Cha EK, Tirsar LA, Schwentner C, et al (2012). Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World J Urol, 30, 847-52. DOI |
8 | Edwards TJ, Dickinson AJ, Natale S, et al (2006). A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int, 97, 301-5. DOI ScienceOn |
9 | Grossfeld GD, Litwin MS, Wolf JS Jr, et al (2001). Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology, 57, 604-10. DOI ScienceOn |
10 | Gore JL, Lai J, Setodji CM, et al (2009). Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results- Medicare analysis. Cancer, 115, 988-96. DOI ScienceOn |
11 | Grossfeld GD, Litwin MS, Wolf JS, et al (2001). Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology, 57, 599-603. DOI ScienceOn |
12 | Grossman HB, Messing E, Soloway M, et al (2005). Detection of bladder cancer using a point-of-care proteomic assay. JAMA, 293, 810-6. DOI ScienceOn |
13 | Kelly JD, Fawcett DP, Goldberg LC (2009). Assessment and management of non-visible haematuria in primary care. BMJ, 338, 227-32. DOI |
14 | Khadra MH, Pickard RS, Charlton M, et al (2000). A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practice. J Urol, 163, 524-7. DOI ScienceOn |
15 | Lotan Y, Capitanio U, Shariat SF, et al (2009). Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int, 103, 1368-74. DOI ScienceOn |
16 | Madeb R, Messing EM (2008). Long-term outcome of home dipstick testing for hematuria. World J Urol, 26, 19-24. DOI |